2008•Xinxiang yixueyuan xuebaoRequires access

Expression and clinical significance of inhibitor of apoptosis protein Survivin in children with acute leukemia

Fan Yan-fen

Open publisher page 0 citations

Abstract

Objective To investigate the expression and clinical significance of inhibitor of apoptosis protein Survivin in children with acute leukemia(AL).Methods Among 49 patients with AL,26 cases were diagnosed first time and weren't treated,23 cases were complete remission after treatment.The expression of Survivin protein was detected by immunohistochemical assay in 49 children with AL and 10 children without malignant blood disease.Results Survivin protein positive expression rate in 26 newly diagnosed children with AL(65.38%)is significantly higher than that in complete remission children(17.39%)and the children in control group(10.00%,P0.017).There is no significant difference in the positive expression of Survivin between the newly diagnosed acute lymphoblastic leukemia(63.16%)and acute myeloblastic leukemiapatients(71.43%,P0.05).Conclusion Survivin may participate in the pathogenesis and progress of AL by inhibiting the apoptosis of tumor cell.It provides a new strategy for the therapy of AL in children.

About this research paper

What this paper is about

Objective To investigate the expression and clinical significance of inhibitor of apoptosis protein Survivin in children with acute leukemia(AL).Methods Among 49 patients with AL,26 cases were diagnosed first time and weren't treated,23 cases were complete remission after treatment.The expression of Survivin protein was detected by immunohistochemical assay in 49 children with AL and 10 children without malignant blood disease.Results Survivin protein positive expression rate in 26 newly diagnosed children with AL(65.38%)is significantly higher than that in complete remission children(17.39%)and the children in control group(10.00%,P0.017).There is no significant difference in the positive expression of Survivin between the newly diagnosed acute lymphoblastic leukemia(63.16%)and acute myeloblastic leukemiapatients(71.43%,P0.05).Conclusion Survivin may participate in the pathogenesis and progress of AL by inhibiting the apoptosis of tumor cell.It provides a new strategy for the therapy of AL in children.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the expression and clinical significance of inhibitor of apoptosis protein Survivin in children with acute leukemia(AL).Methods Among 49 patients with AL,26 cases were diagnosed first time and weren't treated,23 cases were complete remission after treatment.The expression of Survivin protein was detected by immunohistochemical assay in 49 children with AL and 10 children without malignant blood disease.Results Survivin protein positive expression rate in 26 newly diagnosed children with AL(65.38%)is significantly higher than that in complete remission children(17.39%)and the children in control group(10.00%,P0.017).There is no significant difference in the positive expression of Survivin between the newly diagnosed acute lymphoblastic leukemia(63.16%)and acute myeloblastic leukemiapatients(71.43%,P0.05).Conclusion Survivin may participate in the pathogenesis and progress of AL by inhibiting the apoptosis of tumor cell.It provides a new strategy for the therapy of AL in children.

Key concepts: Survivin, Acute myeloblastic leukemia, Inhibitor of apoptosis, Medicine, Apoptosis, Pathogenesis, Acute leukemia, Immunohistochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and clinical significance of inhibitor of apoptosis protein Survivin in children with acute leukemia — Research Paper | ScholarLens